Emmaus Life Sciences, Inc.
USD0.01
+0.00 (+2.30%)
CEO
Willis C. Lee
IPO Date
2000-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.02
Market Cap
$0.00B
Volume
0.00M
| -0.1 |
| 31 Dec 2023 | FY | 95.5% | -12.6% | 7.8% | -10.6% | -0.68 | 0.19 | -1.4 |
| 31 Dec 2022 | FY | 85.9% | -57.8% | 31.2% | -22.0% | -0.90 | 0.12 | -1.2 |
| 31 Dec 2021 | FY | 83.9% | -77.4% | 74.3% | -28.1% | -1.39 | 0.25 | -5.2 |
| 31 Dec 2020 | FY | 90.3% | 5.8% | -25.0% | 2.3% | -3.50 | 0.48 | 44.4 |
| 31 Dec 2019 | FY | 95.2% | -241.0% | 496.2% | -92.2% | -1.76 | 1.26 | -1.5 |
| 30 Sept 2018 | FY | 37.1% | -729.4% | -238.7% | -186.3% | 0.15 | 3.01 | -5.2 |
| 30 Sept 2017 | FY | 58.4% | -5535.3% | -156.4% | -116.7% | 0.01 | 3.68 | -2.3 |
| 30 Sept 2016 | FY | 93.5% | -6981.2% | 2316.2% | -450.0% | -0.36 | 0.79 | -0.6 |
| -0.1 |
| 30 Sept 2025 | Q3 | 92.7% | -61.5% | 3.5% | -10.0% | -0.53 | 0.07 | -0.1 |
| 30 Jun 2025 | Q2 | 94.7% | -40.3% | 2.0% | -4.9% | -0.58 | 0.08 | -0.2 |
| 31 Mar 2025 | Q1 | 90.6% | -96.8% | 4.0% | -10.4% | -0.56 | 0.09 | -0.1 |
| 31 Dec 2024 | Q4 | 90.6% | -53.1% | 3.1% | -7.4% | -0.58 | 0.11 | -0.1 |
| 30 Sept 2024 | Q3 | 92.8% | 33.4% | -3.4% | 6.7% | -0.61 | 0.14 | 0.3 |
| 30 Jun 2024 | Q2 | 95.5% | -40.6% | 3.8% | -8.4% | -0.55 | 0.14 | -0.7 |
| 31 Mar 2024 | Q1 | 89.7% | -173.5% | 8.1% | -14.7% | -0.59 | 0.13 | -0.4 |
| 31 Dec 2023 | Q4 | 97.3% | 17.1% | -2.5% | 3.4% | -0.69 | 0.19 | 1.1 |